Histoplasmose crônica disseminada com lesões exclusivas na boca: relato de caso by Valle, Antonio Carlos F. do et al.
Rev. Inst. Med. trop. S. Paulo
48(2):113-116, March-April, 2006
(1) Department of Infectious Diseases, Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
(2) Department of Micro-Immuno-Parasitology, Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Correspondence to: Dr. Antonio Carlos Francesconi do Valle, Departamento de Doenças Infecciosas, Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365,
21045-900 Rio de Janeiro, RJ, Brasil. E-mail: afvalle@ipec.fiocruz.br
CHRONIC DISSEMINATED HISTOPLASMOSIS WITH LESIONS RESTRICTED
TO THE MOUTH: CASE REPORT
Antonio Carlos F. do VALLE(1), Luiz Carlos MOREIRA(1), Rodrigo ALMEIDA-PAES(2), João S. MOREIRA(1), Cláudia V. PIZZINI(2),
Mauro de Medeiros MUNIZ(2) & Rosely M. ZANCOPÉ-OLIVEIRA(2)
SUMMARY
We report a rare case of chronic disseminated histoplasmosis with several ulcerated lesions in the oral cavity in an alcoholic
patient without human immunodeficiency virus infection, with no detectable signs and symptoms of systemic disease or extraoral
manifestations. Histopathological analysis revealed chronic inflammatory process with granulomas containing Histoplasma-like
organisms. The isolation of Histoplasma capsulatum provided the definitive diagnosis. Treatment with itraconazole resulted in
complete remission of oral lesions. As far we aware, this is the second case report of oral histoplasmosis in an HIV negative patient
described in Brazil.
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INTRODUCTION
Histoplasmosis is a worldwide systemic mycosis caused by
Histoplasma capsulatum. Although the majority of cases present as a
mild to moderate flu-like disease requiring only supportive therapy,
approximately 5% of patients experience more serious pulmonary and
extra pulmonary disease that can be life-threatening if diagnosis is
delayed or if treatment is not initiated rapidly. Definitive diagnosis is
usually made by a combination of culture, detection of the organism
in tissues, measurement of antibodies, or detection of antigen15.
The course of histoplasmosis can be influenced by the immune
status of the host and by their exposure to infective propagules.
Asymptomatic infections are usually result from exposure of a normal
host to low-level microconidia. On the other hand, heavy exposures
lead to clinical disease in more than 75% of patients with normal
immune system16.
Histoplasmosis is clinically classified as a primary acute pulmonary
form that is usually asymptomatic; a chronic pulmonary form that
occurs in the presence of underlying pulmonary disease; and a
disseminated form, which occurs almost exclusively in infants, the
elderly, and in debilitated or immunocompromised patients. The latter
is characterized by the progressive spread of infection to extra
pulmonary sites16, and the lesions in this form may be extra pulmonary
in the oral cavity or intestine. In the absence of effective cell-mediated
immunity infection with H. capsulatum may progress to fulminating
with an often fatal course. The patients affected by this disease complain
of symptoms such as occasional fever, asthenia, weight loss and
odynophagia related to the oral lesions16. Lymphadenopathy and lung
alterations can also be found.
The oral lesions frequently are granulomatous and appear as nodular
ulcerative or vegetative lesions that may be painful, localized on the
oral mucosa, tongue, hard and/or soft palate, or lips. The ulcers have
raised and rolled borders commonly covered by a yellow or grayish
membrane, resembling carcinoma or tuberculosis10.
Disseminated histoplasmosis with oral involvement in immunocom-
petent patient has being rarely described around the world6 or in
Brazil4,12,13. We present a case of the chronic disseminated histoplas-
mosis in an alcohol dependent patient, HIV negative, without other
subjacent underlying disease, with lesions exclusively in the oral cavity.
CASE REPORT
A 48-year-old, smoker for thirty-five years, and alcoholic male
from the urban area of Barra do Piraí - Rio de Janeiro, sought treatment
at the Department of Infectious Diseases at the Instituto de Pesquisa
Clinica Evandro Chagas (FIOCRUZ) for a six-month history of a painful
oral lesion, dysphagia, and weight loss of approximately 6 kg. At that
time, the patient was not taking any medication and had no history of
systemic disease except alcoholism. Also, the patient did not report
previous blood transfusions and surgeries, as well as visits to farms or
caves. General clinical examination demonstrated the patient to be
thin with normal skin color. He was afebrile, well-hydrated, anicteric,
noncyanotic, and without edema. No lymphadenopathy or
hepatosplenomegaly was appreciated on physical examination. The
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abdomen was soft and non rigid with normal bowel sounds. Cardiac
auscultation revealed regular rate and rhythm, and normal breath sound.
Neurological examination did not reveal abnormalities.
The examination of the oral cavity revealed a hypomobile, indurated
tongue, with firm consistency and the presence of crater-like ulcers,
with inflammed base and irregular borders. This lesion was 3 cm in its
widest diameter and was located in the right margin, extending to the
dorsal surface of the tongue. The ulcer border was elevated, white,
well demarcated, and hard. It was friable and bled upon scraping and
was extremely painful to palpation. Another irregular, ulcerated lesion,
with the same characteristics was observed in the medium lateral portion
and dorsal surface of the tongue in the left side. Another lesion with
irregular peripheral margin, granular surface and, painful to palpation
was presented at the posterior hard palate, extending to the soft palate,
tonsil pillar and uvula (Fig. 1).
The floor of the mouth had increased volume without defined limits
with the ventral surface of the tongue and the adjacent structures. The
sublingual carunculae were also increased, without defined shapes and
were considered firm and hard upon palpation. The neck examination
did not reveal lymphadenophaty.
The X-ray of the paranasal sinuses, chest, and abdominal ultra-
sonography did not demonstrate alterations. Antibodies to Epstein Barr
virus, paracoccidioidomycosis, histoplasmosis, HTLV-1, HIV, syphilis,
and cytomegalovirus were negative. An eosinophilia (8% eosinophils)
was detected in blood count. Levels of urea, creatinin, bilirubins, alkaline
phosphatase, GOT, GPT and cortisol (after ACTH stimulation) were
normal. Sputum direct examination was negative in three samples for
fungus and alcohol-acid resistant bacillus. Hemocultures were also
negative. Parasitological examination of feces by Baerman-Moraes
method revealed infection by Strongyloides stercoralis. For this infection
the patient has received albendazole, 400 mg/day during three days.
Biopsy was performed on one of the tongue lesions, and palate
tissue was excised. Both tissue fragments were sent for
histopathological and microbiological examination. Histopathology
revealed pseudoepitheliomatous hyperplasia, with granulomatous
chronic inflammatory process. Furthermore, H. capsulatum-like yeasts
were evident as demonstrated by PAS and Grocott stains.
All oral samples were submitted to mycological assessment. KOH
mounts of all samples were negative. After 15 to 20 days of culture on
Sabouraud Dextrose Agar at room temperature, white to brownish
filamentous colonies were observed on the slants. Microscopic
examination of slide cultures on Potato Dextrose Agar, made under
appropriate biosafety conditions suggested for H. capsulatum research,
revealed septate hyaline hyphae, with globose macroconidia, and
microconidia (Fig. 2a). Conversion to oval yeast cells with single
budding (Fig. 2b), and demonstration of the specific H and M
exoantigens, confirmed H. capsulatum identity.
Fig. 2 - Histoplasma capsulatum stained by lactophenol cotton blue: A. Mould phase showing tuberculate macroconidia and microconidia, B. Oval, single budding yeast cells (400X). C.
Grocott’s stain of the tissue of the tongue, showing Histoplasma-like cells (400X).
Fig. 1 - Lesions due to Histoplasma capsulatum into oral cavity of a HIV negative patient: A. palate lesion, B. tongue lesion.
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The patient was initially treated with oral itraconazole 100 mg
daily. After 60 days, the oral lesion had resolved completely. Two years
after the onset of fungal infection, patient had no signs of recurrent
oral lesions. There was no evidence of persistent H. capsulatum
infection.
DISCUSSION
Oral manifestations of histoplasmosis, although usually described
associated with the chronic disseminated form of the disease, constitute
a rare event in patients HIV negative, without subjacent clinical
disorders. Disseminated histoplasmosis affects mainly the phagocytic
mononuclear system, with bone-marrow involvement resulting in
changes in the blood picture, and often occurs in immunosuppressed
patients. Enlargement of the spleen and liver may be the only gross
abnormalities observed in addition to lung and oral lesions16. Oral
lesions, when present, can manifest in a variety of forms, such as ulcers,
erythematous or vegetative nodules10. Frequently, in cases of
disseminated infection, such lesions appear as the initial clinical
manifestation. Nevertheless, since 1946 few cases of apparently initial
mucocutaneous histoplasmosis in patients without detectable systemic
involvement have been reported6.
Histoplasmosis is worldwide in distribution. The endemic areas are
located in the United States and in Latin America, and it is one of the
most common systemic mycoses in Brazil. Epidemiologic surveys carried
out in our country indicated that this mycosis is endemic in all areas
surveyed showing high frequency of reactors in the Southeastern,
geographical area where Rio de Janeiro is situated3 . Although the cases
of histoplasmosis have been underestimated we believe this mycosis is
a very important health problem in Brazil. Acute pulmonary
histoplasmosis is the most frequent clinical form reported in our country,
with a dry cough, malaise and diffuse pulmonary infiltrates associated
with hilar lymphadenopathy12. This usually resolves without any
treatment but leaves calcified pulmonary lesions. Disseminated forms
are more associated to immunodeficient subjects, notably those suffering
with AIDS4,12. A high prevalence of skin lesions and lung involvement is
observed in Brazilian immunocompromised patients, in comparison with
North American patients7, probably because differences in virulence
between strains isolated in Brazil and United States2. The immuno-
competent individuals in the United States are usually asymptomatic, or
present mild, inespecific symptoms5,17, however, Brazilian patients
without no predisponent risk factor can develop disseminated
histoplasmosis14. Oral histoplasmosis has been frequently reported
associated to HIV-seropositive patients4. As far as we aware, this is the
second reported case of oral histoplasmosis in a HIV negative patient
without detectable systemic involvement described in Brazil13.
Oral histoplasmosis is usually diagnosed after the discovery of lesions
of the upper aero-digestive tracts, and absence of pulmonary signs. These
lesions may remain the only location for a long period1, and can be
misinterpreted as aphthous and/or traumatic ulcers, ulcerative necrotic
gingivitis or stomatitis, other mycoses, cells squamous carcinoma and
lymphomas6,10,15. The oral lesions are initially budding or wart-like and
then develop into ulcerating, indurated and painful lesions1. They are
resulting of hematogenous spread from an unknown infectious focus,
although some investigators suggested that, when no systemic sign or
symptom can be detected, oral histoplasmosis should be considered a
localized disease, and treated as such6. We consider the case presented
in this paper be a chronic disseminated form of the disease since the
patient was alcoholic, and could be in a transient state of immuno-
depression, as well presented characteristic symptoms of this clinical
form of histoplasmosis. The histopathology features were also consistent
with those of a chronic specific infection characterized by the formation
of the diffuse, small granulomas composed of histiocytes, containing
variable numbers of yeast-like H. capsulatum revealed by PAS, and silver
methenamine stain, favoring differential diagnosis with other infectious
diseases15. The patient does not report any risk factor for histoplasmosis.
In fact, about 20% of patients do not present any identified risk factors14,15.
Nonetheless, the isolation of H. capsulatum in culture confirmed the
diagnosis.
In the case described in this paper, the sputum analysis does not
provide diagnosis. However the oral scrapping, a non-invasive proce-
dure, revealed Histoplasma-like yeasts, as well as the H. capsulatum
growth for confirmation of diagnosis. Therefore, we suggest that patient
presenting oral attack, material from the lesions instead of sputum
must be examined, for an efficient diagnosis.
The immunodiffusion test that detects antibodies against the H
and M antigens of H. capsulatum is a reliable methodology for the
presumptive diagnosis of histoplasmosis15. However, it can present low
specificity in cases of immunodeficiency9. All the serum samples from
this case of histoplasmosis showed negative results by immunodiffusion
suggesting the need of inclusion of methodologies more sensitive and
specific, as detection of antigens, for the diagnosis of histoplasmosis.
Amphotericin B is the treatment of choice for immunocompromised
patients with disseminated or limited disease11. However, treatment
with itraconazole was also reported as favorable8 . Our studies
corroborated these data, and in accordance with other authors12, suggest
that, in chronic disseminated histoplasmosis, with localized lesions
without detection of systemic sign or symptoms, drugs with less
toxicity, such as the itraconazole, should be chosen for therapy.
RESUMO
Histoplasmose crônica disseminada com lesões exclusivas na
boca: relato de caso
Reportamos um caso raro de histoplasmose crônica disseminada
com diversas lesões ulceradas na cavidade oral de um paciente alcoó-
latra, sem o vírus da imunodeficiência humana, com nenhum outro
sinal detectável ou sintomas de doença sistêmica ou manifestações
extra-orais. Análise histopatológica revelou processo inflamatório crô-
nico com granulomas contendo organismos fúngicos. O isolamento
do Histoplasma capsulatum forneceu o diagnóstico definitivo. Trata-
mento com itraconazol resultou numa remissão completa das lesões
orais. De acordo com nosso conhecimento, este é o segundo caso re-
portado de histoplasmose oral em um paciente HIV negativo descrito
no Brasil.
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